Author

Changhong Li

Observed name: Li, Changhong

Institution: Hua Medicine (China)

Observed institution: Hua Medicine (China)

ORCID: 0009-0006-4433-7547

Observed ORCID: 0009-0006-4433-7547

OpenAlex ID: A5114185327

Impaired GK-GKRP interaction rather than direct GK activation worsens lipid profiles and contributes to long-term complications: a Mendelian randomization study

2024 · Ke Wang, Mai Shi, et al. · Cardiovascular Diabetology · 12

Functional and Mechanistic Explanation for the Unique Clinical Success of the Glucokinase Activator Dorzagliatin in the Treatment of Type 2 Diabetes

2025 · Jeff Roman, Yue Yuan, et al. · Diabetes · 9

Dorzagliatin shows potential in preventing cognitive impairment in diabetes: evidence from Mendelian randomization analysis and animal study

2026 · Jiangxia Ni, Ke Wang, et al. · Frontiers in Endocrinology · 1

A case of mucopolysaccharidosis I with severely increased albuminuria and Graves’ disease, and functional analysis of previously uncharacterized variant

2026 · Kun Dong, Junran J. Peng, et al. · Orphanet Journal of Rare Diseases

A functional and mechanistic explanation for the unique clinical success of the glucokinase activator dorzagliatin for treatment of type 2 diabetes

2025 · Jeff Roman, Yue Yuan, et al.

A functional and mechanistic explanation for the unique clinical success of the glucokinase activator dorzagliatin for treatment of type 2 diabetes

2025 · Jeff Roman, Yue Yuan, et al.

Works count: 8

Citation count: 22

H-index: 2

I10-index: 1